Completed OBSERVATIONAL NCT01727427

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

Sponsor: G. d'Annunzio University

Conditions Unsuspected Pulmonary Embolism

Interventions Heparin, fondaparinux, vitamin-K antagonists, aspirin

Updated 9 times since 2017 Last updated: Aug 7, 2019 Started: Nov 30, 2012 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Unsuspected Pulmonary Embolism and is currently completed. G. d'Annunzio University leads this study, which shows 9 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Sep 2019 — Jan 2021 [monthly]

Completed

▶ Show 4 earlier versions

Jun 2018 — Sep 2019 [monthly]

Completed

Status: Recruiting → Completed
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

G. d'Annunzio University

Data source: G. d'Annunzio University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amiens, France , Amsterdam, Netherlands , Arras, France , Barcelona, Spain , Benidorm, Spain , Bergamo, Italy , Bordeaux, France , Brest, France , Castelnau, France , Chieti, Italy and 22 more locations